AIDS Patient Care Research Articles

Antiviral Briefs

AIDS Patient Care and STDsVol. 20, No. 12 Antiviral BriefsPublished Online:27 Dec 2006https://doi.org/10.1089/apc.2006.20.887AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byNovel Compounds for the Treatment of HIV Type-1 Infection1 April 2009 | Antiviral Chemistry and Chemotherapy, Vol. 19, No. 5 Volume 20Issue 12Dec 2006 InformationCopyright 2006, Mary Ann Liebert, Inc.To cite this article:Antiviral Briefs.AIDS Patient Care and STDs.Dec 2006.887-889.http://doi.org/10.1089/apc.2006.20.887Published in Volume: 20 Issue 12: December 27, 2006PDF download

Long-Term Follow-Up of Patients with Initial Early Virologic Failure After Being Treated with Once-Daily Tenofovir/Abacavir/Lamivudine

AIDS Patient Care and STDsVol. 20, No. 9 Letter to the EditorLong-Term Follow-Up of Patients with Initial Early Virologic Failure After Being Treated with Once-Daily Tenofovir/Abacavir/LamivudineHomayoon Khanlou and Charles FarthingHomayoon KhanlouSearch for more papers by this author and Charles FarthingSearch for more papers by this authorPublished Online:20 Sep 2006https://doi.org/10.1089/apc.2006.20.604AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Long-Term Follow-Up of Patients with Initial Early Virologic Failure After Being Treated with Once-Daily Tenofovir/Abacavir/Lamivudine." , 20(9), pp. 604–605FiguresReferencesRelatedDetails Volume 20Issue 9Sep 2006 InformationCopyright 2006, Mary Ann Liebert, Inc.To cite this article:Homayoon Khanlou and Charles Farthing.Long-Term Follow-Up of Patients with Initial Early Virologic Failure After Being Treated with Once-Daily Tenofovir/Abacavir/Lamivudine.AIDS Patient Care and STDs.Sep 2006.604-605.http://doi.org/10.1089/apc.2006.20.604Published in Volume: 20 Issue 9: September 20, 2006PDF download

Treating HIV Infection with One Pill Per Day

AIDS Patient Care and STDsVol. 20, No. 9 EditorialTreating HIV Infection with One Pill Per DayJeffrey LaurenceJeffrey LaurenceSearch for more papers by this authorPublished Online:20 Sep 2006https://doi.org/10.1089/apc.2006.20.601AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byAntiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection6 November 2017 | HIV Medicine, Vol. 19, No. 2Single-Tablet Regimens in HIV Therapy20 February 2014 | Infectious Diseases and Therapy, Vol. 3, No. 1Single-tablet regimens in HIV: does it really make a difference?4 October 2013 | Current Medical Research and Opinion, Vol. 30, No. 1 Volume 20Issue 9Sep 2006 InformationCopyright 2006, Mary Ann Liebert, Inc.To cite this article:Jeffrey Laurence.Treating HIV Infection with One Pill Per Day.AIDS Patient Care and STDs.Sep 2006.601-603.http://doi.org/10.1089/apc.2006.20.601Published in Volume: 20 Issue 9: September 20, 2006PDF download

No Genteel Cause

AIDS Patient Care and STDsVol. 20, No. 7 A Tribute to Mathilde Krim, Ph.D. Founding Co-chair of amfAR The Foundation for AIDS ResearchNo Genteel CauseKenneth ColeKenneth ColeSearch for more papers by this authorPublished Online:13 Jul 2006https://doi.org/10.1089/apc.2006.20.451AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "No Genteel Cause." , 20(7), pp. 451–452FiguresReferencesRelatedDetailsCited byIn Gratitude: Personal Memories of the Late Dr. Mathilde Krim (July 9, 1926–January 15, 2018) Jeffrey Laurence1 March 2018 | AIDS Patient Care and STDs, Vol. 32, No. 3 Volume 20Issue 7Jul 2006 InformationCopyright 2006, Mary Ann Liebert, Inc.To cite this article:Kenneth Cole.No Genteel Cause.AIDS Patient Care and STDs.Jul 2006.451-452.http://doi.org/10.1089/apc.2006.20.451Published in Volume: 20 Issue 7: July 13, 2006PDF download

Thank You, Dr. Krim

AIDS Patient Care and STDsVol. 20, No. 7 Thank You, Dr. KrimLarry KramerLarry KramerSearch for more papers by this authorPublished Online:13 Jul 2006https://doi.org/10.1089/apc.2006.20.453AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byIn Gratitude: Personal Memories of the Late Dr. Mathilde Krim (July 9, 1926–January 15, 2018) Jeffrey Laurence1 March 2018 | AIDS Patient Care and STDs, Vol. 32, No. 3 Volume 20Issue 7Jul 2006 InformationCopyright 2006, Mary Ann Liebert, Inc.To cite this article:Larry Kramer.Thank You, Dr. Krim.AIDS Patient Care and STDs.Jul 2006.453-455.http://doi.org/10.1089/apc.2006.20.453Published in Volume: 20 Issue 7: July 13, 2006PDF download

Supporting Basic Research: Discovering a New Class of Anti-HIV Drug

AIDS Patient Care and STDsVol. 20, No. 7 Supporting Basic Research: Discovering a New Class of Anti-HIV DrugCarl WildCarl WildSearch for more papers by this authorPublished Online:13 Jul 2006https://doi.org/10.1089/apc.2006.20.472AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetails Volume 20Issue 7Jul 2006 InformationCopyright 2006, Mary Ann Liebert, Inc.To cite this article:Carl Wild.Supporting Basic Research: Discovering a New Class of Anti-HIV Drug.AIDS Patient Care and STDs.Jul 2006.472-475.http://doi.org/10.1089/apc.2006.20.472Published in Volume: 20 Issue 7: July 13, 2006PDF download

Increased Incidence of Genital Herpes after HAART Initiation: A Frequent Presentation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected Patients

AIDS Patient Care and STDsVol. 20, No. 3 Letter to the EditorIncreased Incidence of Genital Herpes after HAART Initiation: A Frequent Presentation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected PatientsPierre Couppié, Frédérique Sarazin, Emmanuel Clyti, Myriam El Guedj, Tania Vaz, Dominique Sainte-Marie, Christian Marty, and Dr. Mathieu NacherPierre CouppiéSearch for more papers by this author, Frédérique SarazinSearch for more papers by this author, Emmanuel ClytiSearch for more papers by this author, Myriam El GuedjSearch for more papers by this author, Tania VazSearch for more papers by this author, Dominique Sainte-MarieSearch for more papers by this author, Christian MartySearch for more papers by this author, and Dr. Mathieu NacherSearch for more papers by this authorPublished Online:20 Mar 2006https://doi.org/10.1089/apc.2006.20.143AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byIntravenous cidofovir for pseudotumoral genital herpes simplex virus infection in two persons living with human immunodeficiency virus ( HIV )24 January 2023 | International Journal of Dermatology, Vol. 128Diagnosis and Management of Genital Herpes: Key Questions and Review of the Evidence for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines13 April 2022 | Clinical Infectious Diseases, Vol. 74, No. Supplement_2Asian guidelines for genital herpesJournal of Infection and Chemotherapy, Vol. 27, No. 10Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected personsAIDS, Vol. 32, No. 17Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)–Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2–Coinfected Individuals23 December 2015 | Journal of Infectious Diseases, Vol. 213, No. 10Immunological Signaling During Herpes Simplex Virus-2 and Cytomegalovirus Vaginal Shedding After Initiation of Antiretroviral Treatment6 April 2016 | Open Forum Infectious Diseases, Vol. 3, No. 2Risk factors for incident HSV-2 infections among a prospective cohort of HIV-1-discordant couples in China2 July 2015 | Sexually Transmitted Infections, Vol. 92, No. 1Herpes Simplex Virus Type 2 Serostatus Is Not Associated with Inflammatory or Metabolic Markers in Antiretroviral Therapy-Treated HIV Darrell H.S. Tan, Janet M. Raboud, Leah Szadkowski, Tae Joon Yi, Brett Shannon, Rupert Kaul, W. Conrad Liles, and Sharon L. Walmsley16 November 2014 | AIDS Research and Human Retroviruses, Vol. 31, No. 3Incidence of Herpes Simplex Virus Type 2 Infections in Africa: A Systematic Review11 July 2014 | Open Forum Infectious Diseases, Vol. 1, No. 2Immune Reconstitution Inflammatory Syndrome9 April 2014Perianal Skin Conditions4 October 2013Reactivation of Herpes Simplex Virus Type 2 After Initiation of Antiretroviral Therapy28 June 2013 | The Journal of Infectious Diseases, Vol. 208, No. 5Immune reconstitution inflammatory syndromeAIDS, Vol. 26, No. 6Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV18 January 2011 | Brain, Vol. 134, No. 4Immune Reconstitution Inflammatory Syndrome25 March 2011 | Advances in Dental Research, Vol. 23, No. 1Tumour-like presentations of anogenital herpes simplex in HIV-positive patients1 April 2011 | International Journal of STD & AIDS, Vol. 22, No. 4Neurologic Consequences of the Immune Reconstitution Inflammatory Syndrome (IRIS)10 August 2010 | Current Neurology and Neuroscience Reports, Vol. 10, No. 6Risk factors for immune reconstitution inflammatory syndrome under combination antiretroviral therapy can be aetiology-specific1 August 2010 | International Journal of STD & AIDS, Vol. 21, No. 8Neurological complications of immune reconstitution in HIV-infected populations24 November 2009 | Annals of the New York Academy of Sciences, Vol. 1184, No. 1Increased Risk of Genital Ulcer Disease in Women During the First Month After Initiating Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 52, No. 5Genital and Perianal Herpes Simplex Simulating Neoplasia in Patients with AIDS Marina Mosunjac, Jaemin Park, Yun F. (Wayne) Wang, Talaat Tadros, Momin Siddiqui, Mahir Bagirov, and James Little20 March 2009 | AIDS Patient Care and STDs, Vol. 23, No. 3Actualización en el tratamiento del herpes genitalActas Dermo-Sifiliográficas, Vol. 100, No. 1Complications of Acquired Immunodeficiency SyndromeUpdate on the Treatment of Genital HerpesActas Dermo-Sifiliográficas (English Edition), Vol. 100, No. 1Cutaneous manifestations of immune reconstitution inflammatory syndromeCurrent Opinion in HIV and AIDS, Vol. 3, No. 4Oral Manifestations after Immune Reconstitution in HIV Patients on Haart1 May 2008 | International Journal of STD & AIDS, Vol. 19, No. 5Case Report: Immune Reconstitution Inflammatory Syndrome Associated with Disseminated Mycobacterial Infection in Patients with AIDS Felipe Francisco Tuon, Grace Carvajal Mulatti, Walkyria Pereira Pinto, Francisco Oscar De Siqueira Franca, and Ronaldo Cesar Gryschek21 August 2007 | AIDS Patient Care and STDs, Vol. 21, No. 8 Volume 20Issue 3Mar 2006 InformationCopyright 2006, Mary Ann Liebert, Inc.To cite this article:Pierre Couppié, Frédérique Sarazin, Emmanuel Clyti, Myriam El Guedj, Tania Vaz, Dominique Sainte-Marie, Christian Marty, and Dr. Mathieu Nacher.Increased Incidence of Genital Herpes after HAART Initiation: A Frequent Presentation of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV-Infected Patients.AIDS Patient Care and STDs.Mar 2006.143-145.http://doi.org/10.1089/apc.2006.20.143Published in Volume: 20 Issue 3: March 20, 2006PDF download

Quality of life and cost-effectiveness of anti-HCV therapy in HIV-infected patients

Quality of life studies in chronic hepatitis C using specific questionnaires have been performed in mono-infected patients; however, these studies have just begun in HIV-HCV co-infected patients. The questionnaires used in mono-infected patients are not well adapted for co-infected patients and need to be redesigned. Typically, co-infected patients have multiple symptoms that may be attributable to HIV, to HCV, to a combination of both diseases or even to side effects related to drug therapy. These patients usually need substitutive therapy to manage side effects related to HCV therapy, particularly anaemia, leukopenia and depression. There are no cost-effectiveness studies published on the current HCV standard therapy with pegylated interferon and ribavirin. However, there is some research on the old standard interferon and ribavirin, which shows that HCV therapy is cost-effective. Cost-effectiveness studies in co-infected patients will have to take into account variables that do not affect mono-infected patients, such as the different levels of CD4, the increase in the fibrosis progression rate and the use of other expensive drugs for the management of side effects. Currently, the literature does not provide adequate information on the effect of HCV infection on the quality of life of HIV-HCV co-infected patients or the most cost-effective HCV therapy.

Letter to the Editor: Use of Amitriptyline to Offset Sleep Disturbances Caused by Efavirenz

AIDS Patient Care and STDsVol. 19, No. 7 Letter to the Editor: Use of Amitriptyline to Offset Sleep Disturbances Caused by EfavirenzBarbara S. Koppel and Chetan BharelBarbara S. KoppelSearch for more papers by this author and Chetan BharelSearch for more papers by this authorPublished Online:29 Jul 2005https://doi.org/10.1089/apc.2005.19.419AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Letter to the Editor: Use of Amitriptyline to Offset Sleep Disturbances Caused by Efavirenz." , 19(7), pp. 419–420FiguresReferencesRelatedDetailsCited ByHuman Immunodeficiency Virus/AIDSAssociations between sleep parameters, non-communicable diseases, HIV status and medications in older, rural South Africans23 November 2018 | Scientific Reports, Vol. 8, No. 1A Systematic Review of the Psychiatric Side-Effects of Efavirenz12 April 2011 | AIDS and Behavior, Vol. 15, No. 8Sleep Disturbances in Women With HIV or AIDSNursing Research, Vol. 57, No. 5Treating HIV Infection with One Pill Per Day Jeffrey Laurence20 September 2006 | AIDS Patient Care and STDs, Vol. 20, No. 9 Volume 19Issue 7Jul 2005 InformationCopyright 2005, Mary Ann Liebert, Inc.To cite this article:Barbara S. Koppel and Chetan Bharel.Letter to the Editor: Use of Amitriptyline to Offset Sleep Disturbances Caused by Efavirenz.AIDS Patient Care and STDs.Jul 2005.419-420.http://doi.org/10.1089/apc.2005.19.419Published in Volume: 19 Issue 7: July 29, 2005PDF download

Drug Developments and STD News

AIDS Patient Care and STDsVol. 19, No. 7 Drug Developments and STD NewsPublished Online:29 Jul 2005https://doi.org/10.1089/apc.2005.19.469AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetails Volume 19Issue 7Jul 2005 InformationCopyright 2005, Mary Ann Liebert, Inc.To cite this article:Drug Developments and STD News.AIDS Patient Care and STDs.Jul 2005.469-472.http://doi.org/10.1089/apc.2005.19.469Published in Volume: 19 Issue 7: July 29, 2005PDF download

Estimated Extent of Cross-Resistance to Ritonavir-Boosted Protease Inhibitors Among Protease Inhibitors-Experienced Patients: Implications for Tipranavir Use

AIDS Patient Care and STDsVol. 19, No. 2 Letter to the EditorEstimated Extent of Cross-Resistance to Ritonavir-Boosted Protease Inhibitors Among Protease Inhibitors-Experienced Patients: Implications for Tipranavir UseOscar Gallego, Carmen De Mendoza, Angélica Corral, Ana Barrios, and Dr. Vincent SorianoOscar GallegoSearch for more papers by this author, Carmen De MendozaSearch for more papers by this author, Angélica CorralSearch for more papers by this author, Ana BarriosSearch for more papers by this author, and Dr. Vincent SorianoSearch for more papers by this authorPublished Online:16 Feb 2005https://doi.org/10.1089/apc.2005.19.67AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByTipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients11 April 2007 | Expert Opinion on Pharmacotherapy, Vol. 8, No. 6Performance of Six Different Ritonavir-Boosted Protease Inhibitor–Based Regimens in Heavily Antiretroviral-Experienced HIV-Infected Patients14 January 2015 | HIV Clinical Trials, Vol. 7, No. 4An Update and Review of Antiretroviral TherapyPharmacotherapy, Vol. 26, No. 8Tipranavir: a protease inhibitor for multi-drug resistant HIV-122 December 2005 | Expert Opinion on Investigational Drugs, Vol. 15, No. 1 Volume 19Issue 2Feb 2005 InformationCopyright 2005, Mary Ann Liebert, Inc.To cite this article:Oscar Gallego, Carmen De Mendoza, Angélica Corral, Ana Barrios, and Dr. Vincent Soriano.Estimated Extent of Cross-Resistance to Ritonavir-Boosted Protease Inhibitors Among Protease Inhibitors-Experienced Patients: Implications for Tipranavir Use.AIDS Patient Care and STDs.Feb 2005.67-69.http://doi.org/10.1089/apc.2005.19.67Published in Volume: 19 Issue 2: February 16, 2005PDF download

Accessibility and Longevity of Internet Citations in a Clinical AIDS Journal

Little is known about the accessibility and longevity of Internet references in medical and scientific journals. This is particularly problematic in the ever changing field of HIV/AIDS. We examined all issues of AIDS Patient Care and STDs between 2001 and 2004 to test the use and accessibility of Internet citations during this period. The results were compared to findings from a similar evaluation by Hester and colleagues in 2004 of oncology journals. We found that Internet referencing increased from a mean of 0.7% (range, 0.0%-2.1%) of all citations in 2001 to a mean of 3.5% (range, 0.0%-11.2%) in 2004. As the period of time increased from an article's publication, the proportion of inactive Internet references increased (21.3% [1 year] to 41.7% [4 years]). These findings demonstrate the need to adapt new citation policies to facilitate the accessibility of referenced Internet information.

The experts speak. Metabolic complications associated with HIV infection and antiretroviral therapy. Interview by Vicki Glaser.

William Powderly, M.D., is Professor of Medicine at Washington University School of Medicine in St. Louis, Missouri. He received his M.D. from University College Dublin in Ireland and completed Internal Medicine training in Dublin. He did his fellowship in Infectious Disease at Washington University School of Medicine and Barnes-Jewish Hospital. Dr. Powderly is currently Principal Investigator of the National Institutes of Health (NIH)-funded AIDS Clinical Trials Unit at Washington University, which is part of the Adult AIDS Clinical Trials Group. Dr. Powderly is an Associate Editor of AIDS Patient Care and STDs.

Drug Developments and STD News

AIDS Patient Care and STDsVol. 17, No. 12 Drug Developments and STD NewsDrug Developments and STD NewsPublished Online:5 Jul 2004https://doi.org/10.1089/108729103771928735AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byScreening for cervical cancer among Israeli lesbian womenInternational Nursing Review, Vol. 56, No. 4 Volume 17Issue 12Dec 2003 To cite this article:Drug Developments and STD News.AIDS Patient Care and STDs.Dec 2003.669-672.http://doi.org/10.1089/108729103771928735Published in Volume: 17 Issue 12: July 5, 2004PDF download

The experts speak. Changing landscape of opportunistic infections. Interview by Vicki Glaser.

William Powderly, M.D., is Professor of Medicine at Washington University School of Medicine in St. Louis, Missouri. Dr. Powderly joined the faculty in the Infectious Disease Division at the university in 1987 and became codirector of the division in 1995. He received his M.D. degree from University College Dublin in Ireland and completed internal medicine training in Dublin. He did his fellowship in infectious disease at Washington University School of Medicine and Barnes-Jewish Hospital. He is a Fellow of the Royal College of Physicians of Ireland. He has served on numerous national and international committees, especially in the area of AIDS-related clinical research and is currently Vice-Chair of the Adult AIDS Clinical Trials Group and chair of its Scientific Steering Committee. Dr. Powderly has been actively involved in HIV-related clinical research for the last 15 years. He is currently Principal Investigator of the National Institutes of Health (NIH)-funded AIDS Clinical Trials Unit at Washington University, which is part of the Adult AIDS Clinical Trials Group. His own research originally focused on opportunistic infections, especially fungal infections, including cryptococcal meningitis, candidiasis, and histoplasmosis. More recently, he and his group have concentrated on the emerging toxicities of antiretroviral therapy, especially the metabolic complications seen in patients receiving effective therapy. His group has contributed to available data on insulin resistance, lipid abnormalities, and bone disease. The Washington University Metabolic Group was the first to describe bone disease as a complication of HIV infection, has recently published a more complete study of natural history, and has just completed the first randomized trial of therapy for bone demineralization in HIV disease. Dr. Powderly is an associate editor of AIDS Patient Care and STDs.

Women not talking about STDs.

AIDS Patient Care and STDsVol. 17, No. 8 Drug Developments and STD NewsDrug Developments and STD NewsPublished Online:5 Jul 2004https://doi.org/10.1089/108729103322277466AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetails Volume 17Issue 8Aug 2003 To cite this article:Drug Developments and STD News.AIDS Patient Care and STDs.Aug 2003.435-438.http://doi.org/10.1089/108729103322277466Published in Volume: 17 Issue 8: July 5, 2004PDF download

HIV: How Science Shaped the Ethics

AIDS is a debilitating and fatal disease that was first identified as an infectious disease syndrome in the 1970s. The discovery of a nearly universally fatal infectious and rapidly spreading disease in the post–antibiotics era created apprehension in the medical community and alarm in the general population. Questions about how patients should be handled in medical and nonmedical settings resulted in the ostracizing of many AIDS patients and inappropriate patient management. Scientific investigation into modes of disease transmission and control helped to shape the management of AIDS patient care in such a way that ethical and protective practices could be developed. In this article I discuss some of the ethical questions that were addressed by appropriate scientific inquiry.

Drug Developments and STD News

AIDS Patient Care and STDsVol. 16, No. 6 Drug Developments and STD NewsDrug Developments and STD NewsPublished Online:5 Jul 2004https://doi.org/10.1089/10872910260066741AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Drug Developments and STD News." , 16(6), pp. 305–306FiguresReferencesRelatedDetails Volume 16Issue 6Jun 2002 To cite this article:Drug Developments and STD News.AIDS Patient Care and STDs.Jun 2002.305-306.http://doi.org/10.1089/10872910260066741Published in Volume: 16 Issue 6: July 5, 2004PDF download

Drug Developments and STD News

AIDS Patient Care and STDsVol. 16, No. 3 Drug Developments and STD NewsDrug Developments and STD NewsPublished Online:5 Jul 2004https://doi.org/10.1089/108729102317330490AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Drug Developments and STD News." , 16(3), pp. 137–138FiguresReferencesRelatedDetails Volume 16Issue 3Mar 2002 To cite this article:Drug Developments and STD News.AIDS Patient Care and STDs.Mar 2002.137-138.http://doi.org/10.1089/108729102317330490Published in Volume: 16 Issue 3: July 5, 2004PDF download

HIV/AIDS: perspective on India.

AIDS Patient Care and STDsVol. 15, No. 8 Special Section: AIDS in South and Southeast AsiaHIV/AIDS: Perspective on IndiaBhaswati BhattacharyaBhaswati BhattacharyaSearch for more papers by this authorPublished Online:5 Jul 2004https://doi.org/10.1089/108729101316914458AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited byIL-4 and CXCR4 upregulation in HIV-infected and uninfected individuals from Maharashtra-MumbaiAIDS, Vol. 17, No. 10 Volume 15Issue 8Aug 2001 To cite this article:Bhaswati Bhattacharya.HIV/AIDS: Perspective on India.AIDS Patient Care and STDs.Aug 2001.433-435.http://doi.org/10.1089/108729101316914458Published in Volume: 15 Issue 8: July 5, 2004PDF download